This report examined angioedema among new users of dipeptidyl peptidase IV (DPP IV) inhibitors and/or angiotensin converting enzyme (ACE) inhibitors in the Mini-Sentinel Distributed Database (MSDD). This analysis includes two reports:
- Report 1: We examined angioedema among individuals with incident exposure to either DPP IV inhibitors or ACE inhibitors.
- Report 2: We examined angioedema among individuals with concomitant exposures to both DPP IV inhibitors and ACE inhibitors.
The study period includes data from October 16, 2006 to December 31, 2012. We distributed this request to 18 Data Partners on December 20, 2013.